CME Group Q3 Adjusted Earnings, Revenue Rise

CME Group reported Q3 adjusted earnings of $3.02 per share, beating FactSet estimates of $2.99. Revenue also increased. The company's stock has risen 6.22% year-to-date and 8.14% over the past year. Investors may find these results relevant for trading decisions.

Original reporting
Published Oct 21, 2026, 11:25 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CME
Bullish
high confidence
Mentioned
$CME
Relevance
8/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CMEBullishHigh
01

Why it matters

The earnings beat may trigger buying interest and lift related exchange‑traded product stocks.

02

Market read

CME's better‑than‑expected earnings could lift financial‑services equities and set tone for the day's market open.

03

What to watch

Guidance outlook and margin trends were not disclosed, which could temper upside.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

CME Group is a leading derivatives exchange operator; its earnings are a key barometer for the broader financial‑services sector.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME Group reported Q3 adjusted EPS of $3.02, topping the FactSet estimate of $2.99.

Expected impact

likely upward pressure as the market prices in the earnings beat.

Evidence & confidence

The beat is a fresh primary disclosure for a large‑cap exchange operator; traders typically react positively to better‑than‑expected earnings.

Market effects

May boost sentiment for financial services and exchange‑traded product providers.

U.S. markets could open higher on the earnings surprise.

CME's results are watched globally; a beat can influence other derivatives exchanges.

Counterpoint

If the beat is already priced in, the stock could face short‑covering pull‑back.

Key entities

  • CME Group Inc.

    U.S.-listed derivatives exchange operator.

Related articles

$CMEMed

CME Nears Uranium Storage Deal for Physical Futures Contract

CME Group is nearing a deal with ConverDyn (a joint venture between Solstice Advanced Materials and General Atomics) to store uranium for a physical futures contract. The deal, expected to close by year-end, would involve Solstice managing inventories at its Illinois facility. This follows rising uranium demand and prices, with the spot price up over 10% this year.

$CMEMed

Nuclear Revival Spurs CME to Move Ahead on Physical Uranium Contracts

CME Group Inc. is developing a new uranium futures contract backed by physical supplies, partnering with ConverDyn (a joint venture between Solstice Advanced Materials Inc. and General Atomics) for storage. The contract aims to address surging uranium demand amid a global nuclear power revival. Uranium spot prices have tripled over six years, reaching over $90 per pound. The deal is expected to finalize by year-end, pending legal review.

$CMEMed

CME Group is said to plan physically backed uranium futures contract

CME Group is planning to launch a physically backed uranium futures contract, according to Bloomberg. The exchange is close to an agreement with ConverDyn for uranium storage, which could be finalized by year-end. The contract would allow investors to trade uranium backed by physical inventories, potentially improving price discovery and risk management.

$CMEMed

Rate Trading Rose in October and a Fed Governor Leans Toward Backing a December Hike

U.S. stocks fell and 10-year Treasury yield rose on Tuesday after October CPI data showed a 0.4% increase. Fed Governor Waller leaned toward a December rate hike. CME Group, ICE, Tradeweb, Nasdaq, and BGC Group reported increased trading volumes in interest rate products. CME Group's October ADV hit 30 million contracts, up 15% YoY, with interest rate ADV up 28%. ICE reported 14% YoY increase in total October ADV and 40% in interest rates ADV.